跳至主要内容
临床试验/NCT00266682
NCT00266682已完成不适用

Clinical Investigation of the SelectSecure Pacing Lead

Medtronic Cardiac Rhythm and Heart Failure30 个研究点 分布在 3 个国家目标入组 365 人开始时间: 2002年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
365
试验地点
30
主要终点
3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives

研究概览

简要总结

People who have a slow heart beat, or whose heart does not beat on its own, may be in need of an electronic device called a pacemaker. A pacemaker is implanted surgically just under the skin in the upper chest area. This device helps the heart beat at a regular rhythm by sending electrical signals (pacing) directly to the heart tissue through flexible wires called leads. The purpose of this study is to demonstrate that the SelectSecure (Model 3830) lead is safe and effective for both sensing the heart's natural rhythm and pacing the heart when it does not beat on its own. This lead will be studied in both the right atrium and right ventricle. A previously market approved Medtronic lead model will serve as a comparison to prove the safety and effectiveness of the SelectSecure Model.

研究设计

研究类型
Interventional
分配方式
Non Randomized
主要目的
Treatment
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who are in need of a pacemaker that paces in both the right atrium and ventricle.

排除标准

  • Subjects who are in need of an implantable cardioverter defibrillator (ICD).
  • Subjects who have a mechanical or diseased tricuspid valve (a structure in the heart, located between the right atrium and right ventricle, which allows blood to flow from the atrium to the ventricle).
  • Steroid contraindication

结局指标

主要结局

3-month safety (complications and all lead-related adverse events) and efficacy ( pacing and sensing) objectives

次要结局

  • Lead and catheter handling characteristics, and lead impedance

研究者

发起方
Medtronic Cardiac Rhythm and Heart Failure
申办方类型
Industry

研究点 (30)

Loading locations...

相似试验